I would disagree on that they’re going to need a lot of cash for expansion. According to their nov 2024 presentation their current output could be 50 million. All investments regarding production increase has been made and did cost 2-3 million of which 1.3 million has already been paid year end. Due to these investments the yearly output is increased to 108 million yearly. That’s a hell of a return. A one time investment of 2-3 million increasing the yearly output with 58 million to 108 million. I don’t mind people having a different opinion, on the contrary as sometimes a different view from others changes mine. I do not think for one second large investments are needed and a CR is out of the question. There are a lot of holdings in my portfolio where I’m “worried” about a CR, Bioxyne isn’t one of those.
BXN Price at posting:
3.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)